Evidence map›Paper›PMID 31378268›Full record

ArticleTuberculosis (Edinburgh, Scotland)2019

Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies.

Amanda Walz, Pradeep B Lukka, Camron Pearce, Elizabeth Creissen, Miriam Braunstein, Anthony J Hickey, Bernd Meibohm, Mercedes Gonzalez-Juarrero

Open access · greenAbstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Amanda WalzMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523, USA.
Pradeep B LukkaDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Camron PearceMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523, USA.
Elizabeth CreissenMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523, USA.
Miriam BraunsteinDepartment of Microbiology and Immunology, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
Anthony J HickeyEngineering Sciences, RTI International, RTP, Durham, NC, 27709, USA.
Bernd MeibohmDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Mercedes Gonzalez-JuarreroMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523, USA. Electronic address: mercedes.gonzalez-juarrero@colostate.edu.
Colorado State University · USUniversity of Tennessee Health Science Center · USRTI International · USUniversity of North Carolina at Chapel Hill · US

Funding

Aerosol spectinamide-1599 therapy against tuberculosisR01AI120670 · NIAID · COLORADO STATE UNIVERSITY · PI BRAUNSTEIN, MIRIAM S., GONZALEZ-JUARRERO, MERCEDES · 2016 to 2020
$3.6M
Mass Spectrometer for Small Molecule Drug DevelopmentS10OD016226 · OD · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI MEIBOHM, BERND · 2014 to 2014
$316k
NIAID NIH HHS R01 AI120670NIH HHS S10 OD016226
6 · The paper itself

Abstract

Pharmacokinetic/pharmacodynamic studies of anti-tuberculosis agents in animal models of tuberculosis are hampered by the frequent necessity to perform sample bioanalysis outside the biosafety level-3 environment. Thus, each specimen has to undergo tedious and time-consuming sample sterilization procedures that may also affect drug stability. Here, we tested treatment of Mycobacterium tuberculosis (Mtb) infected samples with methanol to sterilize samples while preserving drug integrity for further pharmacokinetic/pharmacodynamic evaluations. Tissue samples harvested from Mtb infected mice were homogenized, incubated in methanol, and tested for sterility. Once sterility was confirmed, the samples were used to determine concentrations of the anti-tuberculosis drug spectinamide-1599 in lung homogenates using liquid chromatography coupled with mass spectrometry. The results demonstrate that methanol sterilizes tissue samples harvested from Mtb infected mice without altering the integrity of the drug in the tissue.

Indexed as

AnimalsAntitubercular AgentsColony Count, MicrobialFeasibility StudiesFemaleLaboratory InfectionLungMethanolMice, Inbred BALB CMicrobial Sensitivity TestsMicrobial ViabilityMycobacterium tuberculosisSpecimen HandlingSpectinomycinStem CellsSterilizationAntitubercular AgentsMethanolspectinamide 1599SpectinomycinMethanolMycobacterium-tuberculosisPharmacokineticsPKSample sterilization

Identifiers

PMID31378268
PMCPMC10226109
OpenAlexW2948400791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.